ATE185275T1 - Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren - Google Patents

Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Info

Publication number
ATE185275T1
ATE185275T1 AT92919588T AT92919588T ATE185275T1 AT E185275 T1 ATE185275 T1 AT E185275T1 AT 92919588 T AT92919588 T AT 92919588T AT 92919588 T AT92919588 T AT 92919588T AT E185275 T1 ATE185275 T1 AT E185275T1
Authority
AT
Austria
Prior art keywords
wide range
stimulate
determinants
against hiv
responses against
Prior art date
Application number
AT92919588T
Other languages
English (en)
Inventor
Jay A Berzofsky
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE185275T1 publication Critical patent/ATE185275T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92919588T 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren ATE185275T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75199891A 1991-08-29 1991-08-29

Publications (1)

Publication Number Publication Date
ATE185275T1 true ATE185275T1 (de) 1999-10-15

Family

ID=25024412

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919588T ATE185275T1 (de) 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Country Status (9)

Country Link
EP (1) EP0601108B1 (de)
JP (1) JPH07501516A (de)
AT (1) ATE185275T1 (de)
AU (1) AU665023B2 (de)
CA (1) CA2114849C (de)
DE (1) DE69230106T2 (de)
DK (1) DK0601108T3 (de)
ES (1) ES2257733T3 (de)
WO (1) WO1993004697A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294322B1 (en) 1988-01-26 2001-09-25 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
IL150961A0 (en) 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
CN110349627B (zh) * 2019-06-27 2021-08-27 杭州纽安津生物科技有限公司 多肽疫苗序列的设计方法及其自动化设计产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
WO1988005051A1 (en) * 1986-12-30 1988-07-14 United States Of America, Represented By The Unite Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins
ATE151638T1 (de) * 1987-02-20 1997-05-15 Genentech Inc Verfahren und zubereitungen für die verwendung von hiv-env-polypeptiden und antikörpern
AU2914889A (en) * 1987-08-28 1989-04-17 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
EP0317804B1 (de) * 1987-11-24 1995-10-04 Abbott Laboratories HIV-Peptide und Methoden für den Nachweis von HIV
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
ES2194836T3 (es) * 1990-09-27 2003-12-01 Tripep Ab Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.

Also Published As

Publication number Publication date
CA2114849A1 (en) 1993-03-18
EP0601108A4 (en) 1997-03-19
AU2569392A (en) 1993-04-05
DE69230106D1 (de) 1999-11-11
AU665023B2 (en) 1995-12-14
EP0601108A1 (de) 1994-06-15
CA2114849C (en) 2007-04-24
WO1993004697A1 (en) 1993-03-18
DK0601108T3 (da) 2000-04-17
ES2257733T3 (es) 2006-08-01
DE69230106T2 (de) 2000-03-30
EP0601108B1 (de) 1999-10-06
JPH07501516A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
DE69233772D1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE3886506D1 (de) Avirulente mikroben und deren verwendungen.
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
ATE149202T1 (de) Gentechnologisch veränderte bakteriophagen und sie enthaltende impfstoffe
FR2697022B1 (fr) Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
ATE210721T1 (de) Verwendung eines mbp peptides zur herstellung eines medikamentes für die behandlung von multipler sclerose
ATE185275T1 (de) Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren
NO941370L (no) Rekombitope peptider
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
DE69007571D1 (de) Peptidfragmente von HIV.
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
ES2176363T3 (es) Peptidos de la proteina gag del vih, su preparacion y su uso.
DE68926245D1 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
DE69122850D1 (de) Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120
OA08974A (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
MX9200711A (es) Un antigeno de fases sanguineas de plasmodium falciparum su preparacion y utilizacion.